Your browser doesn't support javascript.
loading
The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
Suarez-Kelly, Lorena P; Kemper, Gregory M; Duggan, Megan C; Stiff, Andrew; Noel, Tiffany C; Markowitz, Joseph; Luedke, Eric A; Yildiz, Vedat O; Yu, Lianbo; Jaime-Ramirez, Alena Cristina; Karpa, Volodymyr; Zhang, Xiaoli; Carson, William E.
Afiliação
  • Suarez-Kelly LP; The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Kemper GM; The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Duggan MC; The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Stiff A; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.
  • Noel TC; The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Markowitz J; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.
  • Luedke EA; The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Yildiz VO; The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Yu L; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus OH, USA.
  • Jaime-Ramirez AC; The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, USA.
  • Karpa V; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus OH, USA.
  • Zhang X; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
  • Carson WE; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
Oncotarget ; 7(49): 81172-81186, 2016 Dec 06.
Article em En | MEDLINE | ID: mdl-27783987
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Compostos de Boro / Protocolos de Quimioterapia Combinada Antineoplásica / Interferon-alfa / Apoptose / Complexo de Endopeptidases do Proteassoma / Inibidores de Proteassoma / Glicina / Melanoma Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Compostos de Boro / Protocolos de Quimioterapia Combinada Antineoplásica / Interferon-alfa / Apoptose / Complexo de Endopeptidases do Proteassoma / Inibidores de Proteassoma / Glicina / Melanoma Idioma: En Ano de publicação: 2016 Tipo de documento: Article